InvestorsHub Logo
Followers 79
Posts 24434
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Wednesday, 11/30/2016 8:58:44 AM

Wednesday, November 30, 2016 8:58:44 AM

Post# of 27336
CLSN - .75

Celsion Announces Data Monitoring Committee Unanimously Recommends Continuation of Phase III OPTIMA Study of ThermoDox® for Primary Liver Cancer



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.